TY - JOUR
T1 - Factors associated with mortality in bacteremic patients with hematologic malignancies.
AU - Tumbarello, Mario
AU - Spanu Pennestri, Teresa
AU - Caira, Morena
AU - Trecarichi, Enrico Maria
AU - Laurenti, Luca
AU - Montuori, Eva Agostina
AU - Fianchi, Luana
AU - Leone, Fiammetta
AU - Fadda, Giovanni
AU - Cauda, Roberto
AU - Pagano, Livio
PY - 2009
Y1 - 2009
N2 - We conducted a retrospective cohort study to identify risk factors for mortality in a large cohort of hematologic patients with bacteremia.
From 2000 through 2005, bacteremia was diagnosed in 217 patients with hematologic malignancies. The infections were caused only by
Gram-positive organisms in 57.1% (124/217) cases and only by Gram-negative bacteria in 37.8% (82/217); the remaining 5.1% (11/217)
were polymicrobial. The overall 30-day mortality rate was 20.3% (44/217). In multivariate analysis, significant predictors of mortality were
prolonged neutropenia (P b 0.001), acute renal failure (P = 0.002), nosocomial bacteremia (P = 0.009), age N55 years (P = 0.007), and
monomicrobial bacteremia due to antibiotic-resistant Gram-negative bacteria (P = 0.009). Reducing fatal outcomes associated with
bacteremia in patients with hematologic malignancies is a challenge, and the emergence of resistance to the antimicrobials widely used in this
setting is of great concern. Future infection trends must be carefully monitored and treatment guidelines adjusted accordingly.
AB - We conducted a retrospective cohort study to identify risk factors for mortality in a large cohort of hematologic patients with bacteremia.
From 2000 through 2005, bacteremia was diagnosed in 217 patients with hematologic malignancies. The infections were caused only by
Gram-positive organisms in 57.1% (124/217) cases and only by Gram-negative bacteria in 37.8% (82/217); the remaining 5.1% (11/217)
were polymicrobial. The overall 30-day mortality rate was 20.3% (44/217). In multivariate analysis, significant predictors of mortality were
prolonged neutropenia (P b 0.001), acute renal failure (P = 0.002), nosocomial bacteremia (P = 0.009), age N55 years (P = 0.007), and
monomicrobial bacteremia due to antibiotic-resistant Gram-negative bacteria (P = 0.009). Reducing fatal outcomes associated with
bacteremia in patients with hematologic malignancies is a challenge, and the emergence of resistance to the antimicrobials widely used in this
setting is of great concern. Future infection trends must be carefully monitored and treatment guidelines adjusted accordingly.
KW - batteremie
KW - leucemia
KW - batteremie
KW - leucemia
UR - http://hdl.handle.net/10807/6062
M3 - Article
SN - 0732-8893
VL - 64
SP - 320
EP - 326
JO - Diagnostic Microbiology and Infectious Disease
JF - Diagnostic Microbiology and Infectious Disease
ER -